DOI: 10.25881/BPNMSC.2018.52.12.028

Authors

Kosarev E.I., Nesterov S.N., Khanaliev B.B.

Federal State Budgetary Institution «National Medical and Surgical Center named after N.I. Pirogov» of the Ministry of Health of the Russian Federation.

Abstract

The article presents a review of the literature on the use of tumor markers in urological practice is presented, and markers that play a significant role in the diagnosis of cancer are indicated. The problem of diagnosing prostate cancer is particularly noted, namely, the PSA value of the blood, which still remains the most effective, common and affordable method.

Keywords: tumor markers, prostate-specific antigen, prostate cancer.

References

1. Alyaev Yu.G., Bezrukov E.A., Shestiperov P.A. Molekulyarnaya patologiya raka predstatel'noj zhelezy: risk i prognosticheskaya znachimost' osnovnyh markerov // Onkourologiya. 2006. № 2. P. 45-50.

2. Gandbold A., Barhudarov A.A. Osobennosti diagnostiki raka predstatel'noj zhelezy // Elektronnyj nauchno-obrazovatel'nyj vestnik Zdorov'e i obrazovanie v ХХI veke. 2017. № 12. P. 95-97.

3. Gevorkyan A.R. Rol' ambulatornoj urologicheskoj sluzhby v svoevremennoj diagnostike raka predstatel'noj zhelezy // Eksperimental'naya i klinicheskaya urologiya. 2017. № 2. P. 4-9.

4. Glybochko P.V., Hmara T.G., Popkov V.M., Chekhonackaya M.L., Maslyakova G.N., Priezzheva V.N., Ponukalin A.N. Sravnitel'nyj analiz dannyh kliniko-laboratornyh i luchevyh metodov diagnostiki pri rake predstatel'noj zhelezy s uchetom gistomorfologicheskoj gradacii opuholi po shkale Glisona // Saratovskij nauchno-medicinskij zhurnal. 2010. № 2. P. 446-453.

5. Govorov A.V., Vasil'ev A.O., Shiryaev A.A., Suhih S.O., Sidorenkov A.V., Pushkarev A.V., Cyganov D.I., Pushkar' D.Yu. Aktual'nye metody rannej diagnostiki raka predstatel'noj zhelezy // Urologiya. 2017. № 6. P. 101-106.

6. Grigor'eva M.V., Mihajlenko D.S., Efremov G.D., Sivkov A.V. Diagnosticheskaya znachimost' PSA 3 v moche, v zavisimosti ot urovnya syvorotochnogo PSA u obsleduemyh pacientov // Vestnik sovremennyh issledovanij. 2017. № 12. P. 25-26.

7. Kaprin A.D., Kostin A.A., Boyadzhan G.G. Dispanserizaciya muzhskogo naseleniya: znachenie v pervichnom vyyavlenii raka predstatel'noj zhelezy na urovne regional'nogo zdravoohraneniya // Andrologiya i genital'naya hirurgiya. 2016. № 3. P. 43-46.

8. Kirichek A.A., Lyubchenko L.N., Matveev V.B. Risk-adaptirovannyj podhod k skriningu raka predstatel'noj zhelezy // Onkourologiya. 2018. T. 14. № 2. P. 109-121.

9. Korabel'nikov A.S., Zimichev A.A., Geller O.A., Sherman S.I., Belyavskaya E.P. Rak predstatel'noj zhelezy pri normal'nom urovne PSA krovi // Sbornik nauchnyh trudov mezhregional'noj nauchno-prakticheskoj innovacionnoj konferencii. 2016. P. 22-24.

10. Koryakin A.V., Grigor'eva M.V. Sovremennye aspekty vizualizacii i laboratornoj diagnostiki raka predstatel'noj zhelezy // Veles. 2016. № 11. P. 65-71.

11. Nevirovich E.S., Boriskin A.G., Yakovlev V.D., Matveev A.V., Hrushcheva O.L. Analiz znachenij frakcij PSA u muzhchin s urovnem obshchego PSA menee 4 ng/ml // Urologicheskie vedomosti. 2016. № 6. P. 72-73.

12. Peshkov M.N., Generozov E.V., Kostryukova E.S. Evolyuciya markerov raka predstatel'noj zhelezy // Klinicheskaya laboratornaya diagnostika. 2016. № 3. P. 132-140.

13. Peshkov M.N., Generozov E.V., Kostryukova E.S. Evolyuciya markerov raka predstatel'noj zhelezy // Klinicheskaya laboratornaya diagnostika. 2016. № 3. P. 132-140.

14. Popov S.V., Gusejnov R.G., Skryabin O.N., Orlov I.N., Martov A.G. Prognosticheskoe znachenie prostatspecificheskogo antigena pri opredelenii pokazanij k pervichnoj biopsii predstatel'noj zhelezy // Urologiya. 2018. № 3. P. 92-97.

15. Pushkar' D.Yu., Govorov A.V. Diagnosticheskie vozmozhnosti biopsii // Urologiya. 2002. № 6. P. 46-51.

16. Pushkar' D.Yu., Zajcev A.V., Segal A.S., Rasner P.I., Govorov A.V., Bernikov A.N., Gvozdev M.Yu., Kasyan G.R. Urologiya, uchebnik. T.1. 2017. P. 472.

17. Pushkar' D.Yu., Hodyreva L.A., Dudareva A.A., Govorov A.V., Kupriyanov Yu.A. // Rezul'taty skrininga zabolevanij predstatel'noj zhelezy v Moskve // Laboratornaya sluzhba. 2018. T. 7. № 3. P. 100.

18. Rakul S.A., Kamilova T.A., Golota A.S., Shcherbak S.G. Prognosticheskie i prediktivnye biomarkery raka predstatel'noj zhelezy // Onkourologiya. 2017. № 4. P. 111-121.

19. Semyonov S.A., Krasnyj S.A., Karman A.V., Tarend' D.T., Shatilo P.G., Drekov A.G. Skrining raka predstatel'noj zhelezy u molodyh pacientov // Zdravoohranenie. 2017. № 5. P. 11-15.

20. Sosnovskij N.V., Rozengauz E.V., Shkol'nik M.I., Nesterov D.V. Sovremennoe sostoyanie metodov vizualizacii v vyyavlenii raka predstatel'noj zhelezy // Vestnik Severo-Zapadnogo gosudarstvennogo medicinskogo universiteta im. I.I. Mechnikova. 2016. № 4. P. 127-131.

21. Tarend' D.T., Sukonko O.G., Krasnyj S.A., Semenov S.A., Karman A.V. Rezul'taty skrininga raka predstatel'noj zhelezy u muzhchin v vozraste do 55 let // Rossijskij onkologicheskij zhurnal. 2016. № 12. P. 47-50.

22. Hasigov A.V., Tlatov T.K., Engbang Zh.P. Diagnosticheskaya cennost' pal'cevogo rektal'nogo issledovaniya, transrektal'nogo ul'trazvukovogo issledovaniya i syvorotochnogo prostaticheskogo specificheskogo antigena v vyyavlenii raka predstatel'noj zhelezy // Medicinskij vestnik Bashkortostana. 2017. № 3. P. 104-106.

23. Chigireva I.B., Panchenko S.V., Sharafutdinov M.G., Toneeva M.A. Vozmozhnost' primeneniya neinvazivnyh metodov dlya diagnostiki raka predstatel'noj zhelezy // Ul'yanovskij mediko-biologicheskij zhurnal. 2018. № 1. P. 80-85.

24. Shestopalova O.Yu., Kaheli M.A., Matveeva Yu.V. Ocenka effektivnosti ispol'zovaniya sovmeshchennoj MRT- UZI pricel'noj biopsii v diagnostike raka predstatel'noj zhelezy // Luchevaya diagnostika i terapiya. 2017. № 3. P. 70.

25. Armstrong B.K., Barry M.J., Frydenberg M., Gardiner R.A., Haines I., Carter S.M. PSA testing for men at average risk of prostate cancer // Public health research and practice. 2017. № 3. P. 273-721.

26. Boyle P., Koechlin A., Bota M., Boniol M., d'Onofrio A., Zaridze D.G., Perrin P., Fitzpatrick J., Burnett A.L. Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate-specific antigen (PSA) level: a meta-analysis// BJU International. 2016. № 5. P. 731-741.

27. Burgio S.L., Conteduca V., Bianchi E., Menna C., De Giorgi U., Rudnas B., Carrozza F., Fabbri P., Carretta E. PSA flare with abiraterone in patients with metastatic castration-resistant prostate cancer // Clinical genitourinary cancer. 2015. № 1. P. 39-43.

28. Cuppett V.A., Naz R.K., Sikka S.С. Presence of PSA antibodies in seminal plasma of infertile men // Frontiers in Bioscience - Elite. 2017. № 2. P. 258-265.

29. Fontenot P.A., Nehra A., Parker W., Wyre H., Mirza M., Duchene D.A., Holzbeierlein J., Thrasher J.B., Lee E.K. Metastatic prostate cancer in the modern era of PSA screening // International Brazilian Journal of Urology. 2017. Т. 43. № 3. P. 416-421.

30. Grelus A., Nica D.V., Miklos I., Belengeanu V., Ioiart I., Popescu C. Clinical significance of measuring global hydroxymethylation of white blood cell DNA in prostate cancer: comparison to PSA in a pilot exploratory study // International journal of molecular sciences. 2017. № 11. P. 246.

31. Mapelli P., Picchio M., Panebianco V. Prostate cancer recurrence: can PSA guide imaging? // European journal of nuclear medicine and molecular imaging. 2015. № 12. P. 1781-1783.

32. Ng Т.К., Vasilareas D., Mitterdorfer A.J. et al. Prostate cancer detection with digital rectal examination, prostate-specific antigen, transrectal ultrasonography and biopsy in clinical urological practice // BJU Int. 2005. Mar; 95(4). P.545-548.

33. Panach-Navarrete J., Gironés-Montagud A., Sánchez-Cano E., Doménech-Pérez C., Martínez-Jabaloyas J.M. Use of prostatic specific antigen in primary care (PSA) // Semergen. 2017. Т. 43. № 3. P. 189-195.

34. Srivatsa N., Nagaraja H., Shweta S., Raghunath S. Radical prostatectomy for locally advanced prodtate cancers // Indian journal of surgical oncology. 2017. № 2. P. 175-180.

35. Wallis C.J.D., Nam R.K., Haider M.A. Role of MPMRI of the prostate in screening for prostate cancer // Translational Andrology and Urology. 2017. Т. 6. № 3. P. 464-471.

For citation

Kosarev E.I., Nesterov S.N., Khanaliev B.B. The use of tumor markers in urological practice: psa as the most frequently used marker in the differential diagnosis of an oncourologists. Bulletin of Pirogov National Medical & Surgical Center. 2018;13(4):143-146. (In Russ.) https://doi.org/10.25881/BPNMSC.2018.52.12.028